Try our Advanced Search for more refined results
Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG
Case Number:
Case Type:
IPR
Status:
Trial Instituted
Petitioner:
Regeneron Pharmaceuticals, Inc.
Patent Owner:
Novartis Pharma AG
Tech Center:
3700
-
January 25, 2023
Regeneron Gets Novartis Syringe Patent Axed At PTAB
The Patent Trial and Appeal Board has found that more than two dozen claims in a Novartis pre-filled eye injection syringe patent weren't patentable, handing Regeneron a win in a larger legal fight between the parties.
-
July 21, 2022
PTAB Mulls Validity Of Novartis Syringe IP In Regeneron Fight
The Patent Trial and Appeal Board on Thursday considered whether Novartis can beat an invalidity challenge from Regeneron over a pre-filled eye injection syringe patent with an argument that skilled artisans would not have come up with the invention because of safety concerns.
-
October 27, 2021
Regeneron Gets PTAB To Review Syringe Patent On 2nd Go
Regeneron has convinced the Patent Trial and Appeal Board to review claims in a Novartis patent that covers a type of syringe used in eye injections after the Swiss drug giant dropped a related case against Regeneron at the U.S. International Trade Commission.